Stem cell therapy (RejuvaCell)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStem cell therapy (RejuvaCell)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionInsulin release stimulants
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesRejuvacell
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRejuvacell
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A